about
Fat intake and the development of type 2 diabetesPostprandial Increase in Energy Expenditure Correlates with Body Weight Reduction in Patients with Type 2 Diabetes Receiving Diet TherapySelective breeding of mice for different susceptibilities to high fat diet-induced glucose intolerance: Development of two novel mouse lines, Selectively bred Diet-induced Glucose intolerance-Prone and -Resistant.Association of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes.Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes.Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice.Characterization of pancreatic islets in two selectively bred mouse lines with different susceptibilities to high-fat diet-induced glucose intolerance.Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell.Frequency of Achilles Tendon Xanthoma in Patients with Acute Coronary Syndrome.ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism.FoxO1 breaks diabetic heartInvolvement of Rac GTPase activation in phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to ICAM-1.Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.Transgenerational changes of metabolic phenotypes in two selectively bred mouse colonies for different susceptibilities to diet-induced glucose intolerance.Effect of impaired glucose tolerance on atherosclerotic lesion formation: an evaluation in selectively bred mice with different susceptibilities to glucose intolerance.Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes.Severe Insulin-resistant Diabetes due to Insulin Antibodies Associated with Eosinophilia.MicroRNAs in islet hormone secretionLiquid chromatography-tandem mass spectrometry determination of human plasma 1-palmitoyl-2-hydroperoxyoctadecadienoyl-phosphatidylcholine isomers via promotion of sodium adduct formationAssociation of psoriasis with Hashimoto's thyroiditis, Sjögren's syndrome and dermatomyositisGlucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNASelectively Bred Diabetes Models: GK Rats, NSY Mice, and ON MiceSitagliptin improves plasma apolipoprotein profile in type 2 diabetes: A randomized clinical trial of sitagliptin effect on lipid and glucose metabolism (SLIM) studyPotential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-CellsApolipoprotein A-I primes beta cells to increase glucose stimulated insulin secretionExposure to maternal obesity programs sex differences in pancreatic islets of the offspring in miceInsulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistanceA Case of Gitelman Syndrome that Was Difficult to Distinguish from Hypokalemic Periodic Paralysis Caused by Graves' DiseaseMetformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao MiceDifferent pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: aldosterone-producing adenoma and idiopathic hyperaldosteronism
P50
Q26823545-10EBCFCD-A9DD-4C51-9E97-F4794880DEC4Q33567326-88742DC1-D2AC-444E-98B1-28453C048F5EQ33585724-5816036E-D2CB-482E-862B-CA4540517D30Q33607781-EBFAE403-0D56-4C65-B0EE-F2E69C611690Q33622266-26C21DF2-6231-4946-9BD1-F9996DFB4EC2Q35757573-EFC5A024-B0F6-446C-9790-D553A0F5733CQ37472776-E2A3DE9B-4255-42D6-B1BE-B71ECC94BC18Q38711086-8EB467A6-6CE6-48D7-B7F2-9E6939616766Q38751768-293792AE-D25E-4DFB-BE61-6B444E216B12Q39304324-C6787A5B-3905-46D6-9178-E46C554FC3EDQ39554171-D8B7A4F1-A9C6-4C93-8306-77CBCF14F5F9Q39593457-6B88149D-8132-4C57-8291-4FED86ABDEF4Q43203228-BBBEAE93-A0DF-4B71-BBC3-B1B62671D56FQ43836575-E942D2DC-D55F-44AE-820A-EB616CAE0069Q46968438-A00567F1-9089-4CF6-AE16-A6EE51485A4FQ47228231-8CA0E2CF-25C4-4231-9608-8A1760FE5E85Q50935700-9C2DC3E1-4BC9-454B-999B-CDE3258926C0Q60191794-88B1E247-EB00-47F6-A0C6-C6CAED7F23AEQ86105782-AC01A297-9A0C-4CE5-B598-5D93B1F8DC1BQ87101013-232A6AD2-2CC2-457F-8C49-7731FA1C2435Q89580562-4AF4B1F1-279E-447C-A028-C817D9C4B773Q90374845-F7D6C2B7-626A-4526-AF2D-E1A07026AFE0Q90477116-C2100EAD-CD93-4556-821A-649DD2AAAD69Q90539644-D440732B-1FAD-405D-A1E4-A06E96D6D5C0Q91440791-97E108B5-2E2F-40BA-8CA4-E88D63C2C494Q91479539-CBBDCE3D-BBEC-4A6D-A81B-91882FD092E5Q91729337-A1E4A927-5784-4478-ABD3-7B7AF2FFBE7FQ92144277-2DE21C44-716E-4CB9-BC29-3252B2B0533CQ93011588-ED11E1D0-44C8-4054-BE06-D2B207E9A033Q96016990-CEF13806-C4EF-44AF-8D2F-51AD389265CE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mototsugu Nagao
@ast
Mototsugu Nagao
@en
Mototsugu Nagao
@es
Mototsugu Nagao
@nl
type
label
Mototsugu Nagao
@ast
Mototsugu Nagao
@en
Mototsugu Nagao
@es
Mototsugu Nagao
@nl
prefLabel
Mototsugu Nagao
@ast
Mototsugu Nagao
@en
Mototsugu Nagao
@es
Mototsugu Nagao
@nl
P108
P106
P1153
22035744800
P31
P496
0000-0001-6880-5161